Dr. Yanzhi Song
hematology, oncology, stem cell transplantation
hematology, oncology, stem cell transplantation
Overview
Country, City
China, Beijing
Health facility
Beijing GoBroad Boren Hospital
Medical unit
Department of hematopoetic stem cell transplantation
About the doctor
Skills & Expertise
liposomes
tumor
blood
blood clearance
doxorubicin
immunotherapy
macrophages
tumorassociated macrophages
nanoemulsions
antitumor efficacy
modified liposomes
targeted delivery
stem cell
kupffer cells
stem cell transplantation
cell transplantation
acidoctadecylamine conjugate
breast cancer
pegylated emulsions
cancer immunotherapy
antitumor activity
liposomal doxorubicin
antitumor effects
acidcholesterol conjugate
hematopoietic stem cell
hematopoietic stem
tumor immunotherapy
allogeneic hematopoietic stem
improved antitumor activity
acidconjugate modified liposomes
photothermal therapy
pegylated nanoemulsions
doxorubicin liposomes
pegylated liposomes
kupffer cells accelerated
metastasis breast
lung metastasis
tumor therapy
tumor associated macrophages
blood clearance nanoemulsions
cancer immunotherapy targeted
renewal tumorassociated macrophages
enhancing sarcoma chemotherapy
targeted delivery strategy
strategy cancer immunotherapy
inflammation targeted therapy
epirubicin accelerated blood
nanocomplexes cancer immunotherapy
ibrutinib tumorassociated macrophages
Resume
CV (Curriculum Vitae)
Experience
- Associate chief physician of hematopoietic stem cell transplantation department at the Beijing GoBroad Boren Hospital
Awards & Memberships
- Member of the Transplantation and Plasma Exchange Group of the Stem Cell Engineering Technology Branch of the Chinese Society of Biomedical Engineering
- Evidence-based resources rater at the Health Information Research Center of McMaster University
Languages
English
Chinese
Publications
Impact of formulation parameters and circulation time on PEGylated liposomal doxorubicin related hand-foot syndrome.
9 September, 2024
Sialic acid-modified docetaxel cationic liposomes: double targeting of tumor-associated macrophages and tumor endothelial cells.
13 August, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial.
22 July, 2024
FAQ
Where does the doctor practice?
What is the specialization of Dr. Yanzhi Song?
The primary specialization of the doctor is hematology, oncology, stem cell transplantation.
What is the rating of the doctor?
Dr. Yanzhi Song is rated as 9.90 by AiroMedical.
Dr. Yanzhi Song
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Dr. Yanzhi Song